Nicotinamide adenine dinucleotide (NAD+ and NADH) is a key player of cell energy metabolism. 31P-MRS has been demonstrated for in vivo measurement of NAD content and redox state in cat and human brain. We previously demonstrated the feasibility of NAD measurement in mouse brain, and actually we established the in vivo profile of cerebral NAD+, NADH and NAD+/NADH at different ages. This study demonstrated also the feasibility of in vivo measurement of NAD+, NADH and redox state from 20 to 250 days old animals and it opens widely the prospect of studying longitudinally the energy metabolism and redox dysfunction in mouse models of brain pathologies.
This abstract and the presentation materials are available to members only; a login is required.